Lanthipeptide(s) for brtM
brtA1
Leader:
MFFEGDVSLIEEIADQDFEGVAYGA
Core:
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
Core with dehydrations:
CysDhbDhbNDhbFDhaLDhaNALGNNGGWCysDhbLDhbKECysQPNCysN
antiSMASH-DB 4.0 matches for brtA1
93.3%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22995_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ALGN+GGWCTLTKECQPNCN
1
CTTNTFSLSDALGNSGGWCTLTKECQPNCN
30
90.0%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS10200_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ALGN+GGWCTLTKECQ NCN
1
CTTNTFSLSDALGNHGGWCTLTKECQANCN
30
90.0%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15865_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+A+GN+GGWCTLTKECQPNCN
1
CTTNTFSLSDAVGNHGGWCTLTKECQPNCN
30
with 104 more sequence matches
90.0%
NZ_CP016795.1:
Lanthipeptides: BC342_RS18360_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ALGN+GGWCTLTKECQPNC+
1
CTTNTFSLSDALGNHGGWCTLTKECQPNCS
30
90.0%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19760_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCTLTKECQPNCN
1
CTTNTFSLSDWLGNQGGWCTLTKECQPNCN
30
86.7%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS0109895_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+ LGN GGWCTLTKECQPNCN
1
CSTNTFSLSDFLGNQGGWCTLTKECQPNCN
30
86.7%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS28370_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCTLT ECQPNCN
1
CTTNTFSLSDVLGNTGGWCTLTVECQPNCN
30
86.7%
NZ_CP043317.1:
Lanthipeptides: FYC74_RS17680_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS++LGN+GGWCTLTKECQPNC+
1
CTTNTFSLSDSLGNHGGWCTLTKECQPNCS
30
86.7%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02075_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTF+LSN LGNNGGWCTLTKECQ +CN
1
CTTNTFTLSNYLGNNGGWCTLTKECQRSCN
30
86.7%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS30395_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+AL N GGWCTLT ECQPNCN
1
CTTNTFSLSDALTNTGGWCTLTVECQPNCN
30
86.7%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS05175_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+AL N GGWCTLT ECQPNCN
1
CTTNTFSLSDALTNQGGWCTLTVECQPNCN
30
83.3%
NZ_CP047419.1:
Lanthipeptides: GTU71_RS12805_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTF+LSN LGN GGWCTLT ECQPNC
1
CTTNTFTLSNVLGNQGGWCTLTVECQPNC
29
80.0%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00165_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTF+LS+ LGN GGWCTLTKECQ +CN
1
CTTNTFTLSDYLGNKGGWCTLTKECQRSCN
30
76.7%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33590_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+A GN+G WCTLTKECQ CN
1
CSTNTFSLSDAAGNDGWWCTLTKECQRTCN
30
76.7%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28205_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTF+LS+ LGN+GGWCTLTKE Q NC
1
CTTNTFTLSDFLGNDGGWCTLTKESQNNC
29
70.6%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13825_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCT TKEC P+CN
5
CTTNTFSLSDYLGNTGGWCTATKECMPSCN
34
70.6%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09885_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCT TKEC P+CN
5
CTTNTFSLSDFLGNTGGWCTATKECMPSCN
34
70.0%
NZ_KE384533.1:
Lanthipeptides: K329_RS0118200_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+A GN GGWCTL++EC C
1
CTTNTFSLSDAYGNTGGWCTLSQECMSWC
29
66.7%
NZ_BLIS01000009.1:
Lanthipeptides: GVO03_RS04820_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GN G WCTLT EC C
1
CTTNTFSLSDYWGNKGNWCTLTHECMNWC
29
66.7%
NZ_CP016767.1:
Lanthipeptides: BCV50_RS13410_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GN GGWCT++KEC C
1
CTTNTFSLSDYWGNKGGWCTVSKECMAWC
29
66.7%
NZ_CP061868.1:
Lanthipeptides: IE339_RS06330_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ GN GGWCT T EC C
1
CTTNTFSLSDYWGNKGGWCTATHECMSWCK
30
66.7%
NZ_PCGR01000003.1:
Lanthipeptides: CQS04_RS09620_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GNNG WCT T EC C
1
CTTNTFSLSDYWGNNGNWCTATHECMSWC
29
63.3%
NZ_AP026714.1:
Lanthipeptides: PO853_RS06515_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GN G WCT T EC C
1
CTTNTFSLSDYWGNKGNWCTATHECMGWC
29
63.3%
NZ_CACZYW010000004.1:
Lanthipeptides: HUF10_RS02825_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GNNG WCTL+ EC C
1
CSTNTFSLSDYWGNNGNWCTLSHECMAWC
29
63.3%
NZ_CP027862.1:
Lanthipeptides: allorf_0097945_0098112_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+ GN G WCTLT EC C
1
CSTNTFSLSDYWGNRGYWCTLTHECMSWCK
30
63.3%
NZ_NUIO01000031.1:
Lanthipeptides: CN977_RS23160_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ GN+G WCT T EC C
1
CTTNTFSLSDYWGNDGSWCTATHECLSWCK
30
60.0%
NZ_CP034414.1:
Lanthipeptides: EI692_RS18440_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+ GN GGWCT++ EC C
1
CSTNTFSLSDYWGNKGGWCTISHECMSWCK
30
60.0%
NZ_CP051884.1:
Lanthipeptides: HGK68_RS15125_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GNNG CT+T EC C
1
CSTNTFSLSDYWGNNGWLCTITHECMSWC
29
60.0%
NZ_FMPI01000012.1:
Lanthipeptides: BJR39_RS08305_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GNNG WCT + EC C
1
CSTNTFSLSDYWGNNGNWCTASHECMSWC
29
60.0%
NZ_FNHR01000005.1:
Lanthipeptides: BLQ37_RS05590_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ +GNNG WCT++ EC C
1
CSTNTFSLSDYMGNNGNWCTISHECMAWC
29
60.0%
NZ_MIFN01000022.1:
Lanthipeptides: BHL26_RS15350_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ GN+G WC+L+ EC C
1
CTTNTFSLSDYWGNDGSWCSLSHECMSWCK
30
60.0%
NZ_QGEE01000020.1:
Lanthipeptides: DKP74_RS06160_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GN G WCTL+ EC C
1
CSTNTFSLSDYWGNRGNWCTLSHECMAWC
29
56.7%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06305_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLTKECQPNCN
4
WNISCHLGNTGRFCTLTKECQPNCN
28
56.7%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00770_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGNNG WCT+TKEC P+CN
1
LSRLLGNNGRWCTITKECMPSCN
23
56.2%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27565_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGNNGG+CTLTKEC P+CN
10
LSSWLGNNGGYCTLTKECMPSCN
32
54.5%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS20730_lanthipeptide
5
TFSLSNALGNNGGWCTLTKECQPNCN
30
TFSLS GN+G CTLTKECQ +CN
8
TFSLSGIFGNDGDCCTLTKECQASCN
33
54.5%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS47105_lanthipeptide
3
TNTFSLSNALGNNGGWCTLTKECQPNCN
30
T TF+LS LG+ G CT TKECQP+CN
6
TTTFTLSAQLGDKGDCCTATKECQPSCN
33
53.3%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00385_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGN G CTLTKECQ CN
5
LSRKLGNTGYVCTLTKECQRMCN
27
53.3%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06310_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLTKECQP+CN
4
WNISCHLGNTGQFCTLTKECQPSCN
28
53.3%
NZ_CP063276.1:
Lanthipeptides: IM743_RS02795_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S LGN G WCTLT ECQ NCN
4
YDVSCRLGNKGAWCTLTVECQNNCN
28
53.3%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS13085_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S ALGN G +CTLTKECQ CN
6
MSAALGNRGSYCTLTKECQACCN
28
53.1%
NC_018499.1:
Lanthipeptides: BCK_RS27860_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGN GG+CTLTKEC P+CN
10
LSSWLGNKGGYCTLTKECMPSCN
32
50.0%
NC_006322.1:
Lanthipeptides: BLI_RS20295_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGNNG CT+TKEC P+CN
10
LSKPLGNNGYLCTVTKECMPSCN
32
50.0%
NC_021362.1:
Lanthipeptides: BALI_RS00925_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G WCTLTKECQ +C
4
YNISCQLGNKGQWCTLTKECQRSCK
28
50.0%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS13800_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S LGN G WCTLT ECQ +CN
4
YDISCKLGNKGAWCTLTVECQSSCN
28
50.0%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27215_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGN GG+CTLTKEC +CN
10
LSSWLGNKGGYCTLTKECMSSCN
32
50.0%
NZ_KE384107.1:
Lanthipeptides: G586_RS23925_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS +LGN G +CT+TKECQ CN
6
LSASLGNRGSYCTITKECQACCN
28
50.0%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01725_lanthipeptide
7
SLSNALGNNGGWCTLTKECQPNCN
30
LS +LGN G CTLTKECQ C
5
DLSKSLGNKGYVCTLTKECQKLCR
28
50.0%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01720_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G CTLTKECQ CN
2
WNVSKNLGNKGRICTLTKECQSMCN
26
50.0%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS17475_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGN+G +CTLT EC P+CN
2
LSSLLGNDGKFCTLTVECMPSCN
24
50.0%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21835_lanthipeptide
4
NTFSLSNALGNNGGWCTLTKECQPNC
29
N +++S LGN+G CTLTKEC+P C
3
NFWNISCHLGNDGSVCTLTKECRPAC
28
48.6%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS23445_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
SN LGN+G WCTLTKECQ +CN
13
FSNDLGNHGNWCTLTKECQRSCN
35
47.1%
NZ_BMVL01000013.1:
Lanthipeptides: IE257_RS28650_lanthipeptide
3
TNTFSLSN-ALGNNGGWCTLTKECQPNCN
30
T T+++++ ALGNNG CT+T ECQ NC
5
TVTYTVASWALGNNGHLCTVTVECQKNCQ
33
46.7%
NZ_CKMQ01000043.1:
Lanthipeptides: AE832_RS11585_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S ALGN G CT T ECQ NC
8
ISEALGNKGAVCTGTIECQNNCR
30
44.4%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS25150_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T+ + +S LGNNG CT TKEC P+CN
8
TSTSILISMTLGNNGWVCTATKECMPSCN
36
43.8%
NC_002570.2:
Lanthipeptides: AYT26_RS02480_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLT EC P+CN
8
YNISCRLGNKGAYCTLTVECMPSCN
32
43.8%
NZ_CP043405.1:
Lanthipeptides: FY406_RS04355_lanthipeptide
4
NTFSLSNALGNNGGWCTLTKECQPNCN
30
+TFS+ LGN G CT+T EC NC
8
STFSI--VLGNKGYICTVTVECMRNCQ
32
43.3%
NC_016582.1:
Lanthipeptides: SBI_RS34375_lanthipeptide
13
GNNGGWCTLTKECQPNCN
30
G G +CTL+KECQPNCN
3
GGFGLFCTLSKECQPNCN
20
43.3%
NZ_CP036016.1:
Lanthipeptides: allorf_075467_075682_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ LS LGN+G CTL+ EC+P C
5
WDLSCHLGNDGSTCTLSVECRPAC
28
43.3%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21845_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN+G +CT +KEC P CN
5
WNVSCHLGNDGKYCTASKECMPTCN
29
42.4%
NC_018089.1:
Lanthipeptides: SMUGS5_RS08725_lanthipeptide
4
NTFSLSNALGNNGGWCTLTKECQPNCN
30
+TFS+ LGN G CT+T EC NC+
8
STFSI--VLGNKGYICTVTVECMRNCS
32
41.9%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00170_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
++LS LGNNG CT++ EC CN
6
WNLSCHLGNNGKLCTVSHECAAGCN
30
41.2%
NZ_BQXZ01000001.1:
Lanthipeptides: OCU69_RS05000_lanthipeptide
3
TNTFSLSNALGNNGGWCTLTKECQPNCN
30
T + +LS +GN G CT T ECQ NC+
6
TISITLSVYMGNKGSVCTWTIECQSNCS
33
41.2%
NZ_WITJ01000001.1:
Lanthipeptides: GHI93_RS00065_lanthipeptide
11
ALGNNGGWCTLTKECQPNC
29
ALGNNG CT T ECQ NC
15
ALGNNGYVCTWTHECQANC
33
40.0%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS02100_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
++LS LGN+G CT + EC CN
5
YNLSCHLGNDGKICTFSHECTGGCN
29
40.0%
NZ_CP061033.1:
Lanthipeptides: IAU67_RS09320_lanthipeptide
11
ALGNNGGWCTLTKECQPNCN
30
ALGN G +CT T ECQ C
3
ALGNEGNFCTGTIECQKTCQ
22
39.5%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09360_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S A+GN+G CT T ECQPNCN
16
ISPAMGNDGHLCTATVECQPNCN
38
39.0%
NZ_NTSR01000029.1:
Lanthipeptides: CN358_RS25180_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
+ + LS LGNNG CT T ECQ NCN
13
SADYIKLSIGLGNNGYICTYTVECQKNCN
41
38.9%
NC_017299.1:
Lanthipeptides: H04402_RS03105_lanthipeptide
3
TNTFSLSNALGNNGGWCTLTKECQPNCN
30
T + +LS +GN+G CT T ECQ NC+
6
TISITLSVYMGNDGKVCTWTVECQNNCS
33
38.9%
NZ_CP009280.1:
Lanthipeptides: P40081_RS01820_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T+ + +S LGN+G CT +KEC P+CN
8
TSTSIFISRGLGNDGWVCTWSKECMPSCN
36
38.7%
NZ_GG657754.1:
Lanthipeptides: SSOG_RS49055_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ +S +GN G +CT T ECQ NC
7
YVVSFVMGNLGNFCTATLECQKNC
30
37.8%
NZ_CP016767.1:
Lanthipeptides: BCV50_RS18735_lanthipeptide
2
TTNTFSLSNA----LGNN-GGWCTLTKEC
25
TT+ +S S A LGNN G +CT++ EC
1
TTDAYSKSLANRAGLGNNYGQYCTVSAEC
29
37.8%
NZ_JALAMD010000003.1:
Lanthipeptides: MOB22_RS05100_lanthipeptide
2
TTNTFSLSNA----LGNN-GGWCTLTKEC
25
TT+ +S S A LGNN G +CT++ EC
1
TTDAYSKSLANRAGLGNNYGKYCTVSAEC
29
37.8%
NZ_QKTG01000020.1:
Lanthipeptides: DEI99_RS16920_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S ALGN+G +CT T ECQ NC
13
YGVSWALGNDGNFCTATVECQSNCK
37
37.5%
NZ_CM001792.1:
Lanthipeptides: C794_RS17980_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS GN G +CT+TKECQ NCN
16
LSRLGGNQGWFCTITKECQVNCN
38
36.8%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12370_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ S LGNNG +CT T ECQ NC
14
YGASYVLGNNGNFCTATAECQNNC
37
36.8%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29300_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ S LGNNG +CT T ECQ NC
14
YGASYVLGNNGNFCTATAECQSNC
37
36.7%
NZ_CP022163.1:
Lanthipeptides: MEBOL_RS24465_lanthipeptide
13
GNNGGW-CTLTKECQPNC
29
GN+GGW CT + EC+P C
9
GNSGGWICTYSTECKPFC
26
36.1%
NZ_CP086141.1:
Lanthipeptides: LL065_RS24800_lanthipeptide
9
SNALGNNGGWCTLTKECQPNC
29
S ALGN G CT + ECQ NC
16
SYALGNQGKICTWSVECQNNC
36
36.1%
NZ_JAENHN010000066.1:
Lanthipeptides: JHL18_RS24425_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S LGN G C+LT+ECQ CN
3
SEGLGNQGKKCSLTRECQRLCN
24
35.9%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12955_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S GNNG CT T ECQ NCN
15
YGVSWVAGNNGQVCTATVECQNNCN
39
35.1%
NC_015215.1:
Lanthipeptides: SGGBAA2069_RS00705_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGN+G CT T ECQ C
15
LSIGLGNDGWVCTWTAECQATCR
37
35.1%
NZ_BCEY01000006.1:
Lanthipeptides: GOZ53_RS01290_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S ALGN+G CT T ECQ C
15
ISFALGNDGWICTWTAECQATCK
37
35.1%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16400_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNC
29
+S LGN G CT TKECQ C
16
VSEVLGNKGKVCTGTKECQGTC
37
35.1%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17445_lanthipeptide
5
TFSLSNALGNNGGWCTLTKECQPNC
29
T +S GN G CT TKECQ C
13
TILVSEVFGNKGKVCTGTKECQGTC
37
35.1%
NZ_CP115450.1:
Lanthipeptides: O1G21_RS35415_lanthipeptide
11
ALGNNGGWCTLTKECQPNCN
30
A+GNNG CT+T ECQ NC
17
AMGNNGYLCTVTAECQKNCQ
36
35.0%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07255_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S LGN G CTLT ECQ CN
19
SYILGNPGHVCTLTVECQKKCN
40
33.3%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07655_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S GN+G C++T EC CN
3
SKDWGNDGYLCSVTVECMIICN
24
33.3%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07650_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S GN+G C++T EC CN
3
SKDWGNDGYLCSVTVECMVICN
24
33.3%
NZ_JAGKQT010000007.1:
Lanthipeptides: J2M30_RS09860_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNC
29
T+ ++S+ +GN+G CT T EC NC
8
TSTCIAVSHFVGNDGKVCTYTVECVNNC
35
33.3%
NZ_KV795763.1:
Lanthipeptides: allorf_248182_248337_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S +GN G CT+T EC C
8
SKVIGNRGRVCTVTVECMSVCQ
29
32.4%
NZ_VTZW01000015.1:
Lanthipeptides: FZ103_RS15850_lanthipeptide
9
SNALGNNGGWCTLTKECQPNC
29
S A+GN G CT+T ECQ C
17
SWAVGNEGWACTVTVECQDGC
37
31.6%
NZ_CM000756.1:
Lanthipeptides: BTHUR0011_RS34475_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNC
29
T+ + +S GN G CT T EC NC
9
TSTSIIISETFGNKGKVCTYTVECVNNC
36
31.6%
NZ_JAQFWW010000002.1:
Lanthipeptides: PDT38_RS11330_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T + + S +G+ G CT T ECQ NC
9
TLSCLAASIMIGDKGQVCTGTVECQNNCR
37
31.6%
NZ_LT575476.1:
Lanthipeptides: BN6628_RS02285_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S ALG+ G CT T EC NC
16
SYALGDKGQVCTATVECINNCR
37
31.2%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15515_lanthipeptide
13
GNNGGWCTLTKEC
25
GN+G WCTLT EC
9
GNDGKWCTLTWEC
21
31.0%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25375_lanthipeptide
7
SLSNALGNNGGWCTLTKECQPNCN
30
+ S +GN G CTLT ECQ +CN
19
AASYFMGNPGHVCTLTVECQKSCN
42
30.6%
NZ_CP082942.1:
Lanthipeptides: K8O96_RS09100_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S LGN G C+ ++ECQ CN
3
SKGLGNTGKRCSWSRECQRLCN
24
28.9%
NZ_JACEIQ010000001.1:
Lanthipeptides: H1191_RS00080_lanthipeptide
7
SLSNALGNNGGWCTLTKECQPNCN
30
++S GN+G +CTLT EC P+CN
22
TVSKLGGNDGWYCTLTVECMPSCN
45
28.1%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04105_lanthipeptide
13
GNNGGWCTLTKEC
25
GN+G +CTLT EC
9
GNDGKYCTLTWEC
21
28.1%
NZ_LT745762.1:
Lanthipeptides: B2C77_RS00795_lanthipeptide
13
GNNGGWCTLTKEC
25
GN+G WCT+T EC
10
GNDGKWCTVTWEC
22
27.9%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18255_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S LGN G CT T EC CN
15
MSKILGNKGRICTYTLECTAGCN
37
27.5%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13115_lanthipeptide
11
ALGNNGGWCTLTKECQPNC
29
A+GN G CTL+ ECQ +C
22
AIGNPGWACTLSVECQGSC
40
27.4%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28810_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T T +SN LGN G CT+TKECQ CN
34
TPRTPIISNTLGNKGHACTITKECQNMCN
62
26.2%
NZ_NTWJ01000043.1:
Lanthipeptides: CN427_RS29370_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQ
26
F S LGN+G CT + ECQ
16
FVGSYTLGNDGIMCTTSYECQ
36
23.5%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05345_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
++LS LGN+G CT + EC CN
26
WNLSCHLGNDGKICTYSHECTAGCN
50
23.4%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28820_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+SN LGN G CT+TKECQ CN
42
ISNTLGNKGHACTITKECQNMCN
64
MIBiG 3.1 matches for brtA1
100.0%
BGC0002110 (QKV49893.1):
Lanthipeptide: birimositide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
46.7%
BGC0000517 (BAB04173.1):
Lanthipeptide: haloduracin β or haloduracin α
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLT EC P+CN
4
YNISCRLGNKGAYCTLTVECMPSCN
28
28.2%
BGC0001229 (SBI_06990):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
19
CTLTKECQPNCN
30
CTL+KECQPNCN
28
CTLSKECQPNCN
39
brtA2
Leader:
MEQQDFLGA
Core:
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
Core with dehydrations:
YDELELIELDhaEEEWHGGDhbGPLCysVAADhaVAADhaAAFCysPDhbDhbKCysDhbDhaKCys
antiSMASH-DB 4.0 matches for brtA2
75.0%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15870_lanthipeptide
1
YDELELIELSEEEWHGGT-GPLCVAASVAASAAFCPTTKCTSKC
43
YDELELIEL E+ HGGT P+C+A SVA S AFCPTTKCTSKC
1
YDELELIELGEDVAHGGTTSPVCIATSVAVSTAFCPTTKCTSKC
44
72.1%
NZ_CP016795.1:
Lanthipeptides: BC342_RS37680_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + GGT P+ VA SVAAS AFCPTTKCT +C
1
YDEAELIELSEADVTGGTTPVSVAVSVAASVAFCPTTKCTKEC
43
69.8%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22990_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + GGT P+ +A +VAASAAFCPTTKCT+ C
1
YDEAELIELSEADVTGGTTPVSIAVTVAASAAFCPTTKCTNDC
43
with 87 more sequence matches
67.4%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35805_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + GGT P+ +A +VAAS AFCPT KCTS C
1
YDEAELIELSEADVTGGTTPVSIAVTVAASVAFCPTIKCTSAC
43
67.4%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS41860_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + HGGTGP C+A +A CPTTKCTSKC
1
YDEAELIELSEADNHGGTGPWCIATVTLVTATVCPTTKCTSKC
43
67.4%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS33140_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + HGGTGP C+A SA CPTTKCTS C
1
YDEAELIELSEADTHGGTGPWCIATVTLVSAVACPTTKCTSSC
43
65.1%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS01465_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE EL+ELS+ + +GGTGP CVA A+AA CPTTKCTS+C
1
YDEDELVELSDADTYGGTGPWCVATVTLATAAICPTTKCTSQC
43
62.8%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19755_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + +GGT C+A SAA CPTTKCTS C
1
YDEAELIELSEADTYGGTAAWCIATVTLVSAAMCPTTKCTSAC
43
62.8%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS30040_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE EL+ELS+ + +GGTGP C+A A+AA CPTTKCTS+C
1
YDEAELVELSDADTYGGTGPWCIATVTLATAAICPTTKCTSQC
43
55.8%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS09415_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE EL+ELS+ + +GGT +C ++ A+AA CPTTKCTS+C
1
YDEAELVELSDADAYGGTAWVCATVTL-ATAAICPTTKCTSQC
42
50.0%
NC_016582.1:
Lanthipeptides: SBI_RS34370_lanthipeptide
1
YDELELIELSEEEWHGGTGP-----------LCVAASVAASAAFCPTTKCTSKC
43
+DE EL+ELSE + HGGT P + +V SAAFCPTTKCTS+C
1
WDEAELVELSEADVHGGTDPAVTGLILGIVAIQAGVAVGVSAAFCPTTKCTSRC
54
50.0%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS44045_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAA---SAAFCPTTKCTSKC
43
YDE EL+E+ E + +GGT C + A SA+ CPTTKCTS+C
1
YDEFELVEMGEADVYGGTTWSCAIVTAVATLVSASACPTTKCTSQC
46
47.8%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33595_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAA---SVAASAAFCPTTKCTSKC
43
YDE ELIEL++ E GGT P ++ AA+ + CPT+ C+SKC
1
YDEAELIELADSEAFGGTSPATTSSWTCITAATISICPTSACSSKC
46
44.2%
NZ_KE384107.1:
Lanthipeptides: G586_RS26715_lanthipeptide
13
EWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
E GG P+ V +AAS AFCPT KCTSKC
1
EQAGGVAPV-VPIIIAASTAFCPTIKCTSKC
30
41.9%
NZ_CP009280.1:
Lanthipeptides: P40081_RS37160_lanthipeptide
5
ELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
E L+ W CV +V SA CPTTKCTSKC
7
ETTPLTTSSWP------CVIGAVDISANLCPTTKCTSKC
39
39.5%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09365_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T P VA +A SA FCPTTKCTS+C
7
TTPSSVACGIAVSALFCPTTKCTSQC
32
39.5%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06300_lanthipeptide
13
EWHGGTGPLC---VAASVAASAAFCPTTKCTSKC
43
E +GP+C +A V S AFCPTT CTS C
2
EVRPQSGPVCAVTLAVCVPVSLAFCPTTACTSDC
35
39.5%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09875_lanthipeptide
22
CVAAS--VAASAAFCPTTKCTSKC
43
CVA S V AS + CPTTKCTSKC
5
CVAVSTVVEASISLCPTTKCTSKC
28
37.2%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13815_lanthipeptide
22
CVAAS--VAASAAFCPTTKCTSKC
43
CVA S V AS + CPTTKCTS+C
5
CVAVSTIVDASISLCPTTKCTSQC
28
37.2%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS21935_lanthipeptide
13
EWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
+ GG P+ V ++AAS AFCP+ KC+SKC
1
DAEGGV-PITVPITIAASTAFCPSIKCSSKC
30
35.4%
NZ_LT575476.1:
Lanthipeptides: BN6628_RS02295_lanthipeptide
2
DELELIELSEEEWHGGTGPLCVAASVAA---SAAFCPTTKCTSKC
43
+ELEL+ +E+ G T V SV +A CPT+ CT C
4
NELELLAGNEDVKGGWTPVATVVISVIGLTMNATPCPTSACTKSC
48
34.9%
NZ_LR134317.1:
Lanthipeptides: EL136_RS01690_lanthipeptide
20
PLCVAASVAA----SAAFCPTTKCTSKC
43
P V ASVA SA CPTT CT C
6
PWLVKASVAVTAFISANTCPTTSCTRAC
33
32.6%
NC_006322.1:
Lanthipeptides: BLI_RS20290_lanthipeptide
22
CVAASVAASAAFCPTTKCTSKC
43
C+ A V SA+ CPTTKCTS+C
17
CITAGVTVSASLCPTTKCTSRC
38
32.6%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS52585_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T LCVA +A CPTT C+SKC
3
TSALCVATITLITATMCPTTACSSKC
28
32.6%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS19790_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T P + V +AAFCP+TKCTS C
7
TTPSSLPCGVFVTAAFCPSTKCTSSC
32
32.6%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS29295_lanthipeptide
22
CVAASVAASAAFCPTTKCTSKC
43
C+ A V SA+ CPTTKCTS+C
18
CITAGVTVSASLCPTTKCTSQC
39
32.6%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27550_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P V A++AA+ + CPTTKCTS+C
12
PTIVEATIAATVSICPTTKCTSRC
35
32.6%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13105_lanthipeptide
23
VAASVAASAAF---CPTTKCTSKC
43
VA+ A SAA+ CPTT CTS+C
5
VASVTAISAAWGDGCPTTVCTSRC
28
32.6%
NZ_NVEA01000022.1:
Lanthipeptides: COL15_RS32130_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
Y+E +LIE EE++ T CP+T CT +C
2
YEETQLIENLNEEFNLYT---------------CPSTPCTIQC
29
30.2%
NC_018499.1:
Lanthipeptides: BCK_RS27845_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPTTKCTSKC
15
VAVSLGICPTTKCTSKC
31
30.2%
NZ_CM000721.1:
Lanthipeptides: BCERE0010_RS29355_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P + A++A +A+ CPTTKCTS+C
12
PTIIGATIAVTASLCPTTKCTSRC
35
30.2%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS21840_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
V +VAAS A CPT C+SKC
4
VPCAVAASIALCPTLACSSKC
24
30.2%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27205_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPTTKCTSKC
16
VAISVGLCPTTKCTSKC
32
30.2%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02090_lanthipeptide
29
ASAAFCPTTKCTSKC
43
ASAAFCP+T CTSKC
14
ASAAFCPSTACTSKC
28
30.2%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS18310_lanthipeptide
22
CVAASVAASAAFCPTTKCTSKC
43
CV +V S + CPTTKCTS+C
6
CVGITVTISVSMCPTTKCTSQC
27
27.9%
NZ_CACZYW010000004.1:
Lanthipeptides: HUF10_RS02820_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P+ VA S S CPTT CT C
9
PVIVAVSAYVSDKTCPTTACTRAC
32
27.9%
NZ_CM001792.1:
Lanthipeptides: C794_RS17975_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S AFCPT+ CTS C
18
VAISLAFCPTSACTSDC
34
27.9%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28835_lanthipeptide
21
LCVAASVAASAAFCPTTKCTSKC
43
L AA A +A PT KC+SKC
14
LATAAGGAVISAVLPTLKCSSKC
36
27.9%
NZ_JABBGE010000004.1:
Lanthipeptides: HHL19_RS13570_lanthipeptide
24
AASVAASAAFCPTTKCTSKC
43
A + SA+ CPTTKCTS+C
10
AVATLVSASACPTTKCTSQC
29
27.9%
NZ_KE384533.1:
Lanthipeptides: K329_RS31315_lanthipeptide
20
PLCVAASVAA--SAAFCPTTKCTSKC
43
P V + V+A S CPTT CT +C
2
PTIVISVVSAYVSTNTCPTTSCTDEC
27
27.9%
NZ_LR134483.1:
Lanthipeptides: EL241_RS13590_lanthipeptide
25
ASVAASAAFCPTTKCTSKC
43
+V S A CPT KCTSKC
5
VTVPLSIALCPTAKCTSKC
23
27.9%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20140_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
V S CPTTKCTSKC
16
VGISVGLCPTTKCTSKC
32
27.9%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18265_lanthipeptide
29
ASAAFCPTTKCTSKC
43
ASAA CPTT C+SKC
18
ASAAQCPTTACSSKC
32
27.9%
NZ_QRWZ01000002.1:
Lanthipeptides: DWX18_RS02625_lanthipeptide
17
GTGPLCVAASVAASAAFCPTTKCTSKC
43
G G + V A V+A+ CPT+ CT C
12
GKGVIAVTAFVSANT--CPTSACTRAC
36
25.6%
NC_017299.1:
Lanthipeptides: H04402_RS03100_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
VA++ A SA F T+ CT+KC
5
VASATAVSALFTVTSACTTKC
25
25.6%
NZ_AP026714.1:
Lanthipeptides: PO853_RS06520_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T P+ +A S S CPT+ CT C
6
TIPISIAVSGWISDKTCPTSVCTRAC
31
25.6%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35800_lanthipeptide
32
AFCPTTKCTSKC
43
AFCPTTKCTS C
2
AFCPTTKCTSAC
13
25.6%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25390_lanthipeptide
12
EEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
W P V ++ SA CP+T C+S+C
7
SSWPCAIVPPVVIWTITDSANSCPSTACSSRC
38
25.6%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12360_lanthipeptide
27
VAASAAF---CPTTKCTSKC
43
V ASAA CPT+ CT +C
23
VGASAAMQGGCPTSGCTKRC
42
25.6%
NZ_BQXZ01000001.1:
Lanthipeptides: OCU69_RS05005_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
VA++ A SA F T+ CT+KC
12
VASATAISALFTVTSACTTKC
32
25.6%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27190_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPT +CTSKC
16
VAISVGLCPTNRCTSKC
32
25.6%
NZ_CP039292.1:
Lanthipeptides: E4J16_RS14990_lanthipeptide
17
GTGPLCVAASVAASAAFCPTTKCTSKC
43
GT P + + CPT CTSKC
1
GTTPSSWPCGIGITTTICPTAVCTSKC
27
25.6%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00175_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VAAS A CPT C+S+C
12
VAASTAQCPTLACSSRC
28
25.6%
NZ_JACSPO010000013.1:
Lanthipeptides: H9624_RS14885_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
V A AA FCPT CT++C
14
VIAISAALPDFCPTGACTTRC
34
25.6%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28810_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCT
40
T P ++ + A S A CPT KCT
1
THPTTISLASALSVALCPTFKCT
23
25.6%
NZ_QKTG01000020.1:
Lanthipeptides: DEI99_RS08060_lanthipeptide
28
AASAAFCPTTKCTSKC
43
AA FCPT CTSKC
2
AALPGFCPTGACTSKC
17
25.6%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29290_lanthipeptide
27
VAASAAF---CPTTKCTSKC
43
V ASAA CPT+ CT +C
20
VGASAALQGGCPTSGCTKRC
39
23.3%
NZ_BOSN01000007.1:
Lanthipeptides: KJS43_RS18000_lanthipeptide
24
AASVAASAAFCPTTKCTS
41
A + S A CPTTKC S
9
ATIIPVSLAICPTTKCAS
26
23.3%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28825_lanthipeptide
16
GGTGPLCVAASVAASAAFCPTTKCTSKC
43
G P A A + PT KC+S+C
1
GDITPQTTDALSAVIVSVLPTLKCSSQC
28
23.3%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16390_lanthipeptide
26
SVAASAAFCPTTKCTSKC
43
+V SAA CPT+ CT +C
19
TVTLSAASCPTSACTKQC
36
23.3%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00390_lanthipeptide
17
GTGPLCVAASVAASAAFCPTTKCTSKC
43
GT P + + CPT C+SKC
1
GTTPSSWPCGIGITTTVCPTAACSSKC
27
23.3%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05340_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
+ +V SAA CPT C++KC
5
IPCTVMVSAAVCPTLVCSNKC
25
23.3%
NZ_CP040938.1:
Lanthipeptides: B5772_RS02455_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
+ +V AS A CPT C++KC
5
IPCAVMASTAICPTLVCSNKC
25
23.3%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17435_lanthipeptide
26
SVAASAAFCPTTKCTSKC
43
+V SAA CPT+ CT+ C
17
TVTLSAASCPTSACTNLC
34
23.3%
NZ_CP085411.1:
Lanthipeptides: LIT28_RS29915_lanthipeptide
28
AASAAFCPTTKCTSKC
43
A+ + CPTTKCTS+C
20
GATISVCPTTKCTSRC
35
23.3%
NZ_JAHXMW010000012.1:
Lanthipeptides: KZX51_RS23840_lanthipeptide
12
EEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
W P + ++ SA CP+T C+S+C
7
SSWPCAIVPPVLIWTITDSANSCPSTACSSRC
38
23.3%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12965_lanthipeptide
25
ASVAASAAFCPTTKCTSKC
43
A+ AA FCPT CT++C
14
AATAALPGFCPTGACTTRC
32
23.3%
NZ_JFCR01000001.1:
Lanthipeptides: JQ44_RS10210_lanthipeptide
30
SAAFCPTTKCTSKC
43
S A CPTTKC+S C
13
SVALCPTTKCSSAC
26
23.3%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21840_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P + +++ S A+CPT+KCT +C
6
PCGIGSTITISIAYCPTSKCTERC
29
23.3%
NZ_QNUC01000031.1:
Lanthipeptides: DN396_RS23045_lanthipeptide
28
AASAAFCPTTKCTSKC
43
A+ + CPTTKCTS+C
20
GATISICPTTKCTSRC
35
20.9%
NC_023073.1:
Lanthipeptides: U722_RS19995_lanthipeptide
30
SAAFCPTTKCTS
41
S A CPTTKC S
18
SLAGCPTTKCAS
29
20.9%
NZ_CKMQ01000043.1:
Lanthipeptides: AE832_RS09950_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
V +V +A CPT+ CT C
15
VTFTVTLNAGACPTSGCTKSC
35
20.9%
NZ_CP040417.1:
Lanthipeptides: FE328_RS09035_lanthipeptide
27
VAASAAFCPTTKCTS
41
V S A CP+TKC S
7
VPISLAICPSTKCAS
21
20.9%
NZ_CP101913.1:
Lanthipeptides: NP440_RS09140_lanthipeptide
26
SVAASAAFCPTTKCTS
41
++ SAA CPTT+C S
11
TIPISAAICPTTQCAS
26
20.9%
NZ_JACSPU010000002.1:
Lanthipeptides: H9630_RS06770_lanthipeptide
13
EWHGGTGPLCVAASVAASAAF
33
+ + T PLC+AAS+ A+ F
2
DVNAETTPLCIAASIGATIIF
22
20.9%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15520_lanthipeptide
23
VAASVAASAAFCPTTKCTS
41
+ ++ S A CPTTKC S
10
LTVTIPISLAGCPTTKCAS
28
20.9%
NZ_KQ040792.1:
Lanthipeptides: WH45_RS23705_lanthipeptide
24
AASVAASAAFCPTTKCTS
41
A + S A CPTT+C S
10
ATIIPVSLAICPTTRCAS
27
20.9%
NZ_KV917378.1:
Lanthipeptides: BK581_RS20095_lanthipeptide
26
SVAASAAFCPTTKCTS
41
++ SAA CPTT+C S
12
TIPISAAACPTTQCAS
27
20.9%
NZ_MLKL01000042.1:
Lanthipeptides: BKK45_RS27405_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPT CT C
15
VAVSVKLCPTGVCTKSC
31
20.9%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS31015_lanthipeptide
32
AFCPTTKCTSKC
43
AFCPT+KCT++C
1
AFCPTSKCTTRC
12
20.9%
NZ_PCGR01000003.1:
Lanthipeptides: CQS04_RS09625_lanthipeptide
30
SAAFCPTTKCTSKC
43
SA CPTT CT C
15
SANSCPTTACTRAC
28
18.6%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04090_lanthipeptide
27
VAASAAFCPTTKCTS
41
+ S A CPTT+C S
9
IPISLAACPTTRCAS
23
18.6%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00775_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
+ S A CPTT+C+ +C
7
IPISIALCPTTRCSRRC
23
18.6%
NZ_CP115450.1:
Lanthipeptides: O1G21_RS35405_lanthipeptide
34
CPTTKCTSKC
43
CPTT CTS+C
12
CPTTACTSRC
21
18.6%
NZ_GG657754.1:
Lanthipeptides: SSOG_RS27835_lanthipeptide
34
CPTTKCTSKC
43
CPT+ CTSKC
1
CPTSGCTSKC
10
18.6%
NZ_JANIOB010000033.1:
Lanthipeptides: NQ113_RS28015_lanthipeptide
32
AFCPTTKCTSKC
43
A CPT +CTS+C
21
ALCPTPRCTSRC
32
18.6%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00150_lanthipeptide
30
SAAFCPTTKCTSKC
43
+AA CP+T CT C
18
TAALCPSTACTGDC
31
16.3%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20280_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
V + CP+ CTS+C
17
VNLTKELCPSIPCTSRC
33
16.3%
NZ_NVJC01000007.1:
Lanthipeptides: COM38_RS07270_lanthipeptide
28
AASAAFCPTTKC
39
A+ + CPTTKC
20
GATISVCPTTKC
31
14.0%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27165_lanthipeptide
33
FCPTTKCTSKC
43
CP+ CTS+C
23
LCPSIPCTSRC
33
MIBiG 3.1 matches for brtA2
60.5%
BGC0002110 (QKV49894.1):
Lanthipeptide: birimositide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
TGPLCVAASVAASAAFCPTTKCTSKC
1
TGPLCVAASVAASAAFCPTTKCTSKC
26
32.6%
BGC0001229 (SBI_06989):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
26
SVAASAAFCPTTKCTSKC
43
+V SAAFCPTTKCTS+C
20
AVGVSAAFCPTTKCTSRC
37
Lanthipeptide(s) for brtM_rename1
brtA1
Leader:
MFFEGDVSLIEEIADQDFEGVAYGA
Core:
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
Core with dehydrations:
CysDhbDhbNDhbFDhaLDhaNALGNNGGWCysDhbLDhbKECysQPNCysN
antiSMASH-DB 4.0 matches for brtA1
93.3%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22995_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ALGN+GGWCTLTKECQPNCN
1
CTTNTFSLSDALGNSGGWCTLTKECQPNCN
30
90.0%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS10200_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ALGN+GGWCTLTKECQ NCN
1
CTTNTFSLSDALGNHGGWCTLTKECQANCN
30
90.0%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15865_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+A+GN+GGWCTLTKECQPNCN
1
CTTNTFSLSDAVGNHGGWCTLTKECQPNCN
30
with 104 more sequence matches
90.0%
NZ_CP016795.1:
Lanthipeptides: BC342_RS18360_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ALGN+GGWCTLTKECQPNC+
1
CTTNTFSLSDALGNHGGWCTLTKECQPNCS
30
90.0%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19760_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCTLTKECQPNCN
1
CTTNTFSLSDWLGNQGGWCTLTKECQPNCN
30
86.7%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS0109895_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+ LGN GGWCTLTKECQPNCN
1
CSTNTFSLSDFLGNQGGWCTLTKECQPNCN
30
86.7%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS28370_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCTLT ECQPNCN
1
CTTNTFSLSDVLGNTGGWCTLTVECQPNCN
30
86.7%
NZ_CP043317.1:
Lanthipeptides: FYC74_RS17680_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS++LGN+GGWCTLTKECQPNC+
1
CTTNTFSLSDSLGNHGGWCTLTKECQPNCS
30
86.7%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02075_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTF+LSN LGNNGGWCTLTKECQ +CN
1
CTTNTFTLSNYLGNNGGWCTLTKECQRSCN
30
86.7%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS30395_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+AL N GGWCTLT ECQPNCN
1
CTTNTFSLSDALTNTGGWCTLTVECQPNCN
30
86.7%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS05175_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+AL N GGWCTLT ECQPNCN
1
CTTNTFSLSDALTNQGGWCTLTVECQPNCN
30
83.3%
NZ_CP047419.1:
Lanthipeptides: GTU71_RS12805_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTF+LSN LGN GGWCTLT ECQPNC
1
CTTNTFTLSNVLGNQGGWCTLTVECQPNC
29
80.0%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00165_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTF+LS+ LGN GGWCTLTKECQ +CN
1
CTTNTFTLSDYLGNKGGWCTLTKECQRSCN
30
76.7%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33590_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+A GN+G WCTLTKECQ CN
1
CSTNTFSLSDAAGNDGWWCTLTKECQRTCN
30
76.7%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28205_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTF+LS+ LGN+GGWCTLTKE Q NC
1
CTTNTFTLSDFLGNDGGWCTLTKESQNNC
29
70.6%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13825_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCT TKEC P+CN
5
CTTNTFSLSDYLGNTGGWCTATKECMPSCN
34
70.6%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09885_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ LGN GGWCT TKEC P+CN
5
CTTNTFSLSDFLGNTGGWCTATKECMPSCN
34
70.0%
NZ_KE384533.1:
Lanthipeptides: K329_RS0118200_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+A GN GGWCTL++EC C
1
CTTNTFSLSDAYGNTGGWCTLSQECMSWC
29
66.7%
NZ_BLIS01000009.1:
Lanthipeptides: GVO03_RS04820_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GN G WCTLT EC C
1
CTTNTFSLSDYWGNKGNWCTLTHECMNWC
29
66.7%
NZ_CP016767.1:
Lanthipeptides: BCV50_RS13410_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GN GGWCT++KEC C
1
CTTNTFSLSDYWGNKGGWCTVSKECMAWC
29
66.7%
NZ_CP061868.1:
Lanthipeptides: IE339_RS06330_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ GN GGWCT T EC C
1
CTTNTFSLSDYWGNKGGWCTATHECMSWCK
30
66.7%
NZ_PCGR01000003.1:
Lanthipeptides: CQS04_RS09620_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GNNG WCT T EC C
1
CTTNTFSLSDYWGNNGNWCTATHECMSWC
29
63.3%
NZ_AP026714.1:
Lanthipeptides: PO853_RS06515_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
CTTNTFSLS+ GN G WCT T EC C
1
CTTNTFSLSDYWGNKGNWCTATHECMGWC
29
63.3%
NZ_CACZYW010000004.1:
Lanthipeptides: HUF10_RS02825_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GNNG WCTL+ EC C
1
CSTNTFSLSDYWGNNGNWCTLSHECMAWC
29
63.3%
NZ_CP027862.1:
Lanthipeptides: allorf_0097945_0098112_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+ GN G WCTLT EC C
1
CSTNTFSLSDYWGNRGYWCTLTHECMSWCK
30
63.3%
NZ_NUIO01000031.1:
Lanthipeptides: CN977_RS23160_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ GN+G WCT T EC C
1
CTTNTFSLSDYWGNDGSWCTATHECLSWCK
30
60.0%
NZ_CP034414.1:
Lanthipeptides: EI692_RS18440_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
C+TNTFSLS+ GN GGWCT++ EC C
1
CSTNTFSLSDYWGNKGGWCTISHECMSWCK
30
60.0%
NZ_CP051884.1:
Lanthipeptides: HGK68_RS15125_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GNNG CT+T EC C
1
CSTNTFSLSDYWGNNGWLCTITHECMSWC
29
60.0%
NZ_FMPI01000012.1:
Lanthipeptides: BJR39_RS08305_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GNNG WCT + EC C
1
CSTNTFSLSDYWGNNGNWCTASHECMSWC
29
60.0%
NZ_FNHR01000005.1:
Lanthipeptides: BLQ37_RS05590_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ +GNNG WCT++ EC C
1
CSTNTFSLSDYMGNNGNWCTISHECMAWC
29
60.0%
NZ_MIFN01000022.1:
Lanthipeptides: BHL26_RS15350_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLS+ GN+G WC+L+ EC C
1
CTTNTFSLSDYWGNDGSWCSLSHECMSWCK
30
60.0%
NZ_QGEE01000020.1:
Lanthipeptides: DKP74_RS06160_lanthipeptide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNC
29
C+TNTFSLS+ GN G WCTL+ EC C
1
CSTNTFSLSDYWGNRGNWCTLSHECMAWC
29
56.7%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06305_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLTKECQPNCN
4
WNISCHLGNTGRFCTLTKECQPNCN
28
56.7%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00770_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGNNG WCT+TKEC P+CN
1
LSRLLGNNGRWCTITKECMPSCN
23
56.2%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27565_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGNNGG+CTLTKEC P+CN
10
LSSWLGNNGGYCTLTKECMPSCN
32
54.5%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS20730_lanthipeptide
5
TFSLSNALGNNGGWCTLTKECQPNCN
30
TFSLS GN+G CTLTKECQ +CN
8
TFSLSGIFGNDGDCCTLTKECQASCN
33
54.5%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS47105_lanthipeptide
3
TNTFSLSNALGNNGGWCTLTKECQPNCN
30
T TF+LS LG+ G CT TKECQP+CN
6
TTTFTLSAQLGDKGDCCTATKECQPSCN
33
53.3%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00385_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGN G CTLTKECQ CN
5
LSRKLGNTGYVCTLTKECQRMCN
27
53.3%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06310_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLTKECQP+CN
4
WNISCHLGNTGQFCTLTKECQPSCN
28
53.3%
NZ_CP063276.1:
Lanthipeptides: IM743_RS02795_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S LGN G WCTLT ECQ NCN
4
YDVSCRLGNKGAWCTLTVECQNNCN
28
53.3%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS13085_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S ALGN G +CTLTKECQ CN
6
MSAALGNRGSYCTLTKECQACCN
28
53.1%
NC_018499.1:
Lanthipeptides: BCK_RS27860_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGN GG+CTLTKEC P+CN
10
LSSWLGNKGGYCTLTKECMPSCN
32
50.0%
NC_006322.1:
Lanthipeptides: BLI_RS20295_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGNNG CT+TKEC P+CN
10
LSKPLGNNGYLCTVTKECMPSCN
32
50.0%
NC_021362.1:
Lanthipeptides: BALI_RS00925_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G WCTLTKECQ +C
4
YNISCQLGNKGQWCTLTKECQRSCK
28
50.0%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS13800_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S LGN G WCTLT ECQ +CN
4
YDISCKLGNKGAWCTLTVECQSSCN
28
50.0%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27215_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGN GG+CTLTKEC +CN
10
LSSWLGNKGGYCTLTKECMSSCN
32
50.0%
NZ_KE384107.1:
Lanthipeptides: G586_RS23925_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS +LGN G +CT+TKECQ CN
6
LSASLGNRGSYCTITKECQACCN
28
50.0%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01725_lanthipeptide
7
SLSNALGNNGGWCTLTKECQPNCN
30
LS +LGN G CTLTKECQ C
5
DLSKSLGNKGYVCTLTKECQKLCR
28
50.0%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01720_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G CTLTKECQ CN
2
WNVSKNLGNKGRICTLTKECQSMCN
26
50.0%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS17475_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS+ LGN+G +CTLT EC P+CN
2
LSSLLGNDGKFCTLTVECMPSCN
24
50.0%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21835_lanthipeptide
4
NTFSLSNALGNNGGWCTLTKECQPNC
29
N +++S LGN+G CTLTKEC+P C
3
NFWNISCHLGNDGSVCTLTKECRPAC
28
48.6%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS23445_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
SN LGN+G WCTLTKECQ +CN
13
FSNDLGNHGNWCTLTKECQRSCN
35
47.1%
NZ_BMVL01000013.1:
Lanthipeptides: IE257_RS28650_lanthipeptide
3
TNTFSLSN-ALGNNGGWCTLTKECQPNCN
30
T T+++++ ALGNNG CT+T ECQ NC
5
TVTYTVASWALGNNGHLCTVTVECQKNCQ
33
46.7%
NZ_CKMQ01000043.1:
Lanthipeptides: AE832_RS11585_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S ALGN G CT T ECQ NC
8
ISEALGNKGAVCTGTIECQNNCR
30
44.4%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS25150_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T+ + +S LGNNG CT TKEC P+CN
8
TSTSILISMTLGNNGWVCTATKECMPSCN
36
43.8%
NC_002570.2:
Lanthipeptides: AYT26_RS02480_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLT EC P+CN
8
YNISCRLGNKGAYCTLTVECMPSCN
32
43.8%
NZ_CP043405.1:
Lanthipeptides: FY406_RS04355_lanthipeptide
4
NTFSLSNALGNNGGWCTLTKECQPNCN
30
+TFS+ LGN G CT+T EC NC
8
STFSI--VLGNKGYICTVTVECMRNCQ
32
43.3%
NC_016582.1:
Lanthipeptides: SBI_RS34375_lanthipeptide
13
GNNGGWCTLTKECQPNCN
30
G G +CTL+KECQPNCN
3
GGFGLFCTLSKECQPNCN
20
43.3%
NZ_CP036016.1:
Lanthipeptides: allorf_075467_075682_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ LS LGN+G CTL+ EC+P C
5
WDLSCHLGNDGSTCTLSVECRPAC
28
43.3%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21845_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN+G +CT +KEC P CN
5
WNVSCHLGNDGKYCTASKECMPTCN
29
42.4%
NC_018089.1:
Lanthipeptides: SMUGS5_RS08725_lanthipeptide
4
NTFSLSNALGNNGGWCTLTKECQPNCN
30
+TFS+ LGN G CT+T EC NC+
8
STFSI--VLGNKGYICTVTVECMRNCS
32
41.9%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00170_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
++LS LGNNG CT++ EC CN
6
WNLSCHLGNNGKLCTVSHECAAGCN
30
41.2%
NZ_BQXZ01000001.1:
Lanthipeptides: OCU69_RS05000_lanthipeptide
3
TNTFSLSNALGNNGGWCTLTKECQPNCN
30
T + +LS +GN G CT T ECQ NC+
6
TISITLSVYMGNKGSVCTWTIECQSNCS
33
41.2%
NZ_WITJ01000001.1:
Lanthipeptides: GHI93_RS00065_lanthipeptide
11
ALGNNGGWCTLTKECQPNC
29
ALGNNG CT T ECQ NC
15
ALGNNGYVCTWTHECQANC
33
40.0%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS02100_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
++LS LGN+G CT + EC CN
5
YNLSCHLGNDGKICTFSHECTGGCN
29
40.0%
NZ_CP061033.1:
Lanthipeptides: IAU67_RS09320_lanthipeptide
11
ALGNNGGWCTLTKECQPNCN
30
ALGN G +CT T ECQ C
3
ALGNEGNFCTGTIECQKTCQ
22
39.5%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09360_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S A+GN+G CT T ECQPNCN
16
ISPAMGNDGHLCTATVECQPNCN
38
39.0%
NZ_NTSR01000029.1:
Lanthipeptides: CN358_RS25180_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
+ + LS LGNNG CT T ECQ NCN
13
SADYIKLSIGLGNNGYICTYTVECQKNCN
41
38.9%
NC_017299.1:
Lanthipeptides: H04402_RS03105_lanthipeptide
3
TNTFSLSNALGNNGGWCTLTKECQPNCN
30
T + +LS +GN+G CT T ECQ NC+
6
TISITLSVYMGNDGKVCTWTVECQNNCS
33
38.9%
NZ_CP009280.1:
Lanthipeptides: P40081_RS01820_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T+ + +S LGN+G CT +KEC P+CN
8
TSTSIFISRGLGNDGWVCTWSKECMPSCN
36
38.7%
NZ_GG657754.1:
Lanthipeptides: SSOG_RS49055_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ +S +GN G +CT T ECQ NC
7
YVVSFVMGNLGNFCTATLECQKNC
30
37.8%
NZ_CP016767.1:
Lanthipeptides: BCV50_RS18735_lanthipeptide
2
TTNTFSLSNA----LGNN-GGWCTLTKEC
25
TT+ +S S A LGNN G +CT++ EC
1
TTDAYSKSLANRAGLGNNYGQYCTVSAEC
29
37.8%
NZ_JALAMD010000003.1:
Lanthipeptides: MOB22_RS05100_lanthipeptide
2
TTNTFSLSNA----LGNN-GGWCTLTKEC
25
TT+ +S S A LGNN G +CT++ EC
1
TTDAYSKSLANRAGLGNNYGKYCTVSAEC
29
37.8%
NZ_QKTG01000020.1:
Lanthipeptides: DEI99_RS16920_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S ALGN+G +CT T ECQ NC
13
YGVSWALGNDGNFCTATVECQSNCK
37
37.5%
NZ_CM001792.1:
Lanthipeptides: C794_RS17980_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS GN G +CT+TKECQ NCN
16
LSRLGGNQGWFCTITKECQVNCN
38
36.8%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12370_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ S LGNNG +CT T ECQ NC
14
YGASYVLGNNGNFCTATAECQNNC
37
36.8%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29300_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNC
29
+ S LGNNG +CT T ECQ NC
14
YGASYVLGNNGNFCTATAECQSNC
37
36.7%
NZ_CP022163.1:
Lanthipeptides: MEBOL_RS24465_lanthipeptide
13
GNNGGW-CTLTKECQPNC
29
GN+GGW CT + EC+P C
9
GNSGGWICTYSTECKPFC
26
36.1%
NZ_CP086141.1:
Lanthipeptides: LL065_RS24800_lanthipeptide
9
SNALGNNGGWCTLTKECQPNC
29
S ALGN G CT + ECQ NC
16
SYALGNQGKICTWSVECQNNC
36
36.1%
NZ_JAENHN010000066.1:
Lanthipeptides: JHL18_RS24425_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S LGN G C+LT+ECQ CN
3
SEGLGNQGKKCSLTRECQRLCN
24
35.9%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12955_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+ +S GNNG CT T ECQ NCN
15
YGVSWVAGNNGQVCTATVECQNNCN
39
35.1%
NC_015215.1:
Lanthipeptides: SGGBAA2069_RS00705_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
LS LGN+G CT T ECQ C
15
LSIGLGNDGWVCTWTAECQATCR
37
35.1%
NZ_BCEY01000006.1:
Lanthipeptides: GOZ53_RS01290_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S ALGN+G CT T ECQ C
15
ISFALGNDGWICTWTAECQATCK
37
35.1%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16400_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNC
29
+S LGN G CT TKECQ C
16
VSEVLGNKGKVCTGTKECQGTC
37
35.1%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17445_lanthipeptide
5
TFSLSNALGNNGGWCTLTKECQPNC
29
T +S GN G CT TKECQ C
13
TILVSEVFGNKGKVCTGTKECQGTC
37
35.1%
NZ_CP115450.1:
Lanthipeptides: O1G21_RS35415_lanthipeptide
11
ALGNNGGWCTLTKECQPNCN
30
A+GNNG CT+T ECQ NC
17
AMGNNGYLCTVTAECQKNCQ
36
35.0%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07255_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S LGN G CTLT ECQ CN
19
SYILGNPGHVCTLTVECQKKCN
40
33.3%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07655_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S GN+G C++T EC CN
3
SKDWGNDGYLCSVTVECMIICN
24
33.3%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07650_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S GN+G C++T EC CN
3
SKDWGNDGYLCSVTVECMVICN
24
33.3%
NZ_JAGKQT010000007.1:
Lanthipeptides: J2M30_RS09860_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNC
29
T+ ++S+ +GN+G CT T EC NC
8
TSTCIAVSHFVGNDGKVCTYTVECVNNC
35
33.3%
NZ_KV795763.1:
Lanthipeptides: allorf_248182_248337_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S +GN G CT+T EC C
8
SKVIGNRGRVCTVTVECMSVCQ
29
32.4%
NZ_VTZW01000015.1:
Lanthipeptides: FZ103_RS15850_lanthipeptide
9
SNALGNNGGWCTLTKECQPNC
29
S A+GN G CT+T ECQ C
17
SWAVGNEGWACTVTVECQDGC
37
31.6%
NZ_CM000756.1:
Lanthipeptides: BTHUR0011_RS34475_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNC
29
T+ + +S GN G CT T EC NC
9
TSTSIIISETFGNKGKVCTYTVECVNNC
36
31.6%
NZ_JAQFWW010000002.1:
Lanthipeptides: PDT38_RS11330_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T + + S +G+ G CT T ECQ NC
9
TLSCLAASIMIGDKGQVCTGTVECQNNCR
37
31.6%
NZ_LT575476.1:
Lanthipeptides: BN6628_RS02285_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S ALG+ G CT T EC NC
16
SYALGDKGQVCTATVECINNCR
37
31.2%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15515_lanthipeptide
13
GNNGGWCTLTKEC
25
GN+G WCTLT EC
9
GNDGKWCTLTWEC
21
31.0%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25375_lanthipeptide
7
SLSNALGNNGGWCTLTKECQPNCN
30
+ S +GN G CTLT ECQ +CN
19
AASYFMGNPGHVCTLTVECQKSCN
42
30.6%
NZ_CP082942.1:
Lanthipeptides: K8O96_RS09100_lanthipeptide
9
SNALGNNGGWCTLTKECQPNCN
30
S LGN G C+ ++ECQ CN
3
SKGLGNTGKRCSWSRECQRLCN
24
28.9%
NZ_JACEIQ010000001.1:
Lanthipeptides: H1191_RS00080_lanthipeptide
7
SLSNALGNNGGWCTLTKECQPNCN
30
++S GN+G +CTLT EC P+CN
22
TVSKLGGNDGWYCTLTVECMPSCN
45
28.1%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04105_lanthipeptide
13
GNNGGWCTLTKEC
25
GN+G +CTLT EC
9
GNDGKYCTLTWEC
21
28.1%
NZ_LT745762.1:
Lanthipeptides: B2C77_RS00795_lanthipeptide
13
GNNGGWCTLTKEC
25
GN+G WCT+T EC
10
GNDGKWCTVTWEC
22
27.9%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18255_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+S LGN G CT T EC CN
15
MSKILGNKGRICTYTLECTAGCN
37
27.5%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13115_lanthipeptide
11
ALGNNGGWCTLTKECQPNC
29
A+GN G CTL+ ECQ +C
22
AIGNPGWACTLSVECQGSC
40
27.4%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28810_lanthipeptide
2
TTNTFSLSNALGNNGGWCTLTKECQPNCN
30
T T +SN LGN G CT+TKECQ CN
34
TPRTPIISNTLGNKGHACTITKECQNMCN
62
26.2%
NZ_NTWJ01000043.1:
Lanthipeptides: CN427_RS29370_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQ
26
F S LGN+G CT + ECQ
16
FVGSYTLGNDGIMCTTSYECQ
36
23.5%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05345_lanthipeptide
6
FSLSNALGNNGGWCTLTKECQPNCN
30
++LS LGN+G CT + EC CN
26
WNLSCHLGNDGKICTYSHECTAGCN
50
23.4%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28820_lanthipeptide
8
LSNALGNNGGWCTLTKECQPNCN
30
+SN LGN G CT+TKECQ CN
42
ISNTLGNKGHACTITKECQNMCN
64
MIBiG 3.1 matches for brtA1
100.0%
BGC0002110 (QKV49893.1):
Lanthipeptide: birimositide
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
1
CTTNTFSLSNALGNNGGWCTLTKECQPNCN
30
46.7%
BGC0000517 (BAB04173.1):
Lanthipeptide: haloduracin β or haloduracin α
6
FSLSNALGNNGGWCTLTKECQPNCN
30
+++S LGN G +CTLT EC P+CN
4
YNISCRLGNKGAYCTLTVECMPSCN
28
28.2%
BGC0001229 (SBI_06990):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
19
CTLTKECQPNCN
30
CTL+KECQPNCN
28
CTLSKECQPNCN
39
brtA2
Leader:
MEQQDFLGA
Core:
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
Core with dehydrations:
YDELELIELDhaEEEWHGGDhbGPLCysVAADhaVAADhaAAFCysPDhbDhbKCysDhbDhaKCys
antiSMASH-DB 4.0 matches for brtA2
75.0%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15870_lanthipeptide
1
YDELELIELSEEEWHGGT-GPLCVAASVAASAAFCPTTKCTSKC
43
YDELELIEL E+ HGGT P+C+A SVA S AFCPTTKCTSKC
1
YDELELIELGEDVAHGGTTSPVCIATSVAVSTAFCPTTKCTSKC
44
72.1%
NZ_CP016795.1:
Lanthipeptides: BC342_RS37680_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + GGT P+ VA SVAAS AFCPTTKCT +C
1
YDEAELIELSEADVTGGTTPVSVAVSVAASVAFCPTTKCTKEC
43
69.8%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22990_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + GGT P+ +A +VAASAAFCPTTKCT+ C
1
YDEAELIELSEADVTGGTTPVSIAVTVAASAAFCPTTKCTNDC
43
with 87 more sequence matches
67.4%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35805_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + GGT P+ +A +VAAS AFCPT KCTS C
1
YDEAELIELSEADVTGGTTPVSIAVTVAASVAFCPTIKCTSAC
43
67.4%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS41860_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + HGGTGP C+A +A CPTTKCTSKC
1
YDEAELIELSEADNHGGTGPWCIATVTLVTATVCPTTKCTSKC
43
67.4%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS33140_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + HGGTGP C+A SA CPTTKCTS C
1
YDEAELIELSEADTHGGTGPWCIATVTLVSAVACPTTKCTSSC
43
65.1%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS01465_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE EL+ELS+ + +GGTGP CVA A+AA CPTTKCTS+C
1
YDEDELVELSDADTYGGTGPWCVATVTLATAAICPTTKCTSQC
43
62.8%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19755_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE ELIELSE + +GGT C+A SAA CPTTKCTS C
1
YDEAELIELSEADTYGGTAAWCIATVTLVSAAMCPTTKCTSAC
43
62.8%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS30040_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE EL+ELS+ + +GGTGP C+A A+AA CPTTKCTS+C
1
YDEAELVELSDADTYGGTGPWCIATVTLATAAICPTTKCTSQC
43
55.8%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS09415_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
YDE EL+ELS+ + +GGT +C ++ A+AA CPTTKCTS+C
1
YDEAELVELSDADAYGGTAWVCATVTL-ATAAICPTTKCTSQC
42
50.0%
NC_016582.1:
Lanthipeptides: SBI_RS34370_lanthipeptide
1
YDELELIELSEEEWHGGTGP-----------LCVAASVAASAAFCPTTKCTSKC
43
+DE EL+ELSE + HGGT P + +V SAAFCPTTKCTS+C
1
WDEAELVELSEADVHGGTDPAVTGLILGIVAIQAGVAVGVSAAFCPTTKCTSRC
54
50.0%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS44045_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAA---SAAFCPTTKCTSKC
43
YDE EL+E+ E + +GGT C + A SA+ CPTTKCTS+C
1
YDEFELVEMGEADVYGGTTWSCAIVTAVATLVSASACPTTKCTSQC
46
47.8%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33595_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAA---SVAASAAFCPTTKCTSKC
43
YDE ELIEL++ E GGT P ++ AA+ + CPT+ C+SKC
1
YDEAELIELADSEAFGGTSPATTSSWTCITAATISICPTSACSSKC
46
44.2%
NZ_KE384107.1:
Lanthipeptides: G586_RS26715_lanthipeptide
13
EWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
E GG P+ V +AAS AFCPT KCTSKC
1
EQAGGVAPV-VPIIIAASTAFCPTIKCTSKC
30
41.9%
NZ_CP009280.1:
Lanthipeptides: P40081_RS37160_lanthipeptide
5
ELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
E L+ W CV +V SA CPTTKCTSKC
7
ETTPLTTSSWP------CVIGAVDISANLCPTTKCTSKC
39
39.5%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09365_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T P VA +A SA FCPTTKCTS+C
7
TTPSSVACGIAVSALFCPTTKCTSQC
32
39.5%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06300_lanthipeptide
13
EWHGGTGPLC---VAASVAASAAFCPTTKCTSKC
43
E +GP+C +A V S AFCPTT CTS C
2
EVRPQSGPVCAVTLAVCVPVSLAFCPTTACTSDC
35
39.5%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09875_lanthipeptide
22
CVAAS--VAASAAFCPTTKCTSKC
43
CVA S V AS + CPTTKCTSKC
5
CVAVSTVVEASISLCPTTKCTSKC
28
37.2%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13815_lanthipeptide
22
CVAAS--VAASAAFCPTTKCTSKC
43
CVA S V AS + CPTTKCTS+C
5
CVAVSTIVDASISLCPTTKCTSQC
28
37.2%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS21935_lanthipeptide
13
EWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
+ GG P+ V ++AAS AFCP+ KC+SKC
1
DAEGGV-PITVPITIAASTAFCPSIKCSSKC
30
35.4%
NZ_LT575476.1:
Lanthipeptides: BN6628_RS02295_lanthipeptide
2
DELELIELSEEEWHGGTGPLCVAASVAA---SAAFCPTTKCTSKC
43
+ELEL+ +E+ G T V SV +A CPT+ CT C
4
NELELLAGNEDVKGGWTPVATVVISVIGLTMNATPCPTSACTKSC
48
34.9%
NZ_LR134317.1:
Lanthipeptides: EL136_RS01690_lanthipeptide
20
PLCVAASVAA----SAAFCPTTKCTSKC
43
P V ASVA SA CPTT CT C
6
PWLVKASVAVTAFISANTCPTTSCTRAC
33
32.6%
NC_006322.1:
Lanthipeptides: BLI_RS20290_lanthipeptide
22
CVAASVAASAAFCPTTKCTSKC
43
C+ A V SA+ CPTTKCTS+C
17
CITAGVTVSASLCPTTKCTSRC
38
32.6%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS52585_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T LCVA +A CPTT C+SKC
3
TSALCVATITLITATMCPTTACSSKC
28
32.6%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS19790_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T P + V +AAFCP+TKCTS C
7
TTPSSLPCGVFVTAAFCPSTKCTSSC
32
32.6%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS29295_lanthipeptide
22
CVAASVAASAAFCPTTKCTSKC
43
C+ A V SA+ CPTTKCTS+C
18
CITAGVTVSASLCPTTKCTSQC
39
32.6%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27550_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P V A++AA+ + CPTTKCTS+C
12
PTIVEATIAATVSICPTTKCTSRC
35
32.6%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13105_lanthipeptide
23
VAASVAASAAF---CPTTKCTSKC
43
VA+ A SAA+ CPTT CTS+C
5
VASVTAISAAWGDGCPTTVCTSRC
28
32.6%
NZ_NVEA01000022.1:
Lanthipeptides: COL15_RS32130_lanthipeptide
1
YDELELIELSEEEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
Y+E +LIE EE++ T CP+T CT +C
2
YEETQLIENLNEEFNLYT---------------CPSTPCTIQC
29
30.2%
NC_018499.1:
Lanthipeptides: BCK_RS27845_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPTTKCTSKC
15
VAVSLGICPTTKCTSKC
31
30.2%
NZ_CM000721.1:
Lanthipeptides: BCERE0010_RS29355_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P + A++A +A+ CPTTKCTS+C
12
PTIIGATIAVTASLCPTTKCTSRC
35
30.2%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS21840_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
V +VAAS A CPT C+SKC
4
VPCAVAASIALCPTLACSSKC
24
30.2%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27205_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPTTKCTSKC
16
VAISVGLCPTTKCTSKC
32
30.2%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02090_lanthipeptide
29
ASAAFCPTTKCTSKC
43
ASAAFCP+T CTSKC
14
ASAAFCPSTACTSKC
28
30.2%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS18310_lanthipeptide
22
CVAASVAASAAFCPTTKCTSKC
43
CV +V S + CPTTKCTS+C
6
CVGITVTISVSMCPTTKCTSQC
27
27.9%
NZ_CACZYW010000004.1:
Lanthipeptides: HUF10_RS02820_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P+ VA S S CPTT CT C
9
PVIVAVSAYVSDKTCPTTACTRAC
32
27.9%
NZ_CM001792.1:
Lanthipeptides: C794_RS17975_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S AFCPT+ CTS C
18
VAISLAFCPTSACTSDC
34
27.9%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28835_lanthipeptide
21
LCVAASVAASAAFCPTTKCTSKC
43
L AA A +A PT KC+SKC
14
LATAAGGAVISAVLPTLKCSSKC
36
27.9%
NZ_JABBGE010000004.1:
Lanthipeptides: HHL19_RS13570_lanthipeptide
24
AASVAASAAFCPTTKCTSKC
43
A + SA+ CPTTKCTS+C
10
AVATLVSASACPTTKCTSQC
29
27.9%
NZ_KE384533.1:
Lanthipeptides: K329_RS31315_lanthipeptide
20
PLCVAASVAA--SAAFCPTTKCTSKC
43
P V + V+A S CPTT CT +C
2
PTIVISVVSAYVSTNTCPTTSCTDEC
27
27.9%
NZ_LR134483.1:
Lanthipeptides: EL241_RS13590_lanthipeptide
25
ASVAASAAFCPTTKCTSKC
43
+V S A CPT KCTSKC
5
VTVPLSIALCPTAKCTSKC
23
27.9%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20140_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
V S CPTTKCTSKC
16
VGISVGLCPTTKCTSKC
32
27.9%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18265_lanthipeptide
29
ASAAFCPTTKCTSKC
43
ASAA CPTT C+SKC
18
ASAAQCPTTACSSKC
32
27.9%
NZ_QRWZ01000002.1:
Lanthipeptides: DWX18_RS02625_lanthipeptide
17
GTGPLCVAASVAASAAFCPTTKCTSKC
43
G G + V A V+A+ CPT+ CT C
12
GKGVIAVTAFVSANT--CPTSACTRAC
36
25.6%
NC_017299.1:
Lanthipeptides: H04402_RS03100_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
VA++ A SA F T+ CT+KC
5
VASATAVSALFTVTSACTTKC
25
25.6%
NZ_AP026714.1:
Lanthipeptides: PO853_RS06520_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
T P+ +A S S CPT+ CT C
6
TIPISIAVSGWISDKTCPTSVCTRAC
31
25.6%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35800_lanthipeptide
32
AFCPTTKCTSKC
43
AFCPTTKCTS C
2
AFCPTTKCTSAC
13
25.6%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25390_lanthipeptide
12
EEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
W P V ++ SA CP+T C+S+C
7
SSWPCAIVPPVVIWTITDSANSCPSTACSSRC
38
25.6%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12360_lanthipeptide
27
VAASAAF---CPTTKCTSKC
43
V ASAA CPT+ CT +C
23
VGASAAMQGGCPTSGCTKRC
42
25.6%
NZ_BQXZ01000001.1:
Lanthipeptides: OCU69_RS05005_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
VA++ A SA F T+ CT+KC
12
VASATAISALFTVTSACTTKC
32
25.6%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27190_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPT +CTSKC
16
VAISVGLCPTNRCTSKC
32
25.6%
NZ_CP039292.1:
Lanthipeptides: E4J16_RS14990_lanthipeptide
17
GTGPLCVAASVAASAAFCPTTKCTSKC
43
GT P + + CPT CTSKC
1
GTTPSSWPCGIGITTTICPTAVCTSKC
27
25.6%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00175_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VAAS A CPT C+S+C
12
VAASTAQCPTLACSSRC
28
25.6%
NZ_JACSPO010000013.1:
Lanthipeptides: H9624_RS14885_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
V A AA FCPT CT++C
14
VIAISAALPDFCPTGACTTRC
34
25.6%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28810_lanthipeptide
18
TGPLCVAASVAASAAFCPTTKCT
40
T P ++ + A S A CPT KCT
1
THPTTISLASALSVALCPTFKCT
23
25.6%
NZ_QKTG01000020.1:
Lanthipeptides: DEI99_RS08060_lanthipeptide
28
AASAAFCPTTKCTSKC
43
AA FCPT CTSKC
2
AALPGFCPTGACTSKC
17
25.6%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29290_lanthipeptide
27
VAASAAF---CPTTKCTSKC
43
V ASAA CPT+ CT +C
20
VGASAALQGGCPTSGCTKRC
39
23.3%
NZ_BOSN01000007.1:
Lanthipeptides: KJS43_RS18000_lanthipeptide
24
AASVAASAAFCPTTKCTS
41
A + S A CPTTKC S
9
ATIIPVSLAICPTTKCAS
26
23.3%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28825_lanthipeptide
16
GGTGPLCVAASVAASAAFCPTTKCTSKC
43
G P A A + PT KC+S+C
1
GDITPQTTDALSAVIVSVLPTLKCSSQC
28
23.3%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16390_lanthipeptide
26
SVAASAAFCPTTKCTSKC
43
+V SAA CPT+ CT +C
19
TVTLSAASCPTSACTKQC
36
23.3%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00390_lanthipeptide
17
GTGPLCVAASVAASAAFCPTTKCTSKC
43
GT P + + CPT C+SKC
1
GTTPSSWPCGIGITTTVCPTAACSSKC
27
23.3%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05340_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
+ +V SAA CPT C++KC
5
IPCTVMVSAAVCPTLVCSNKC
25
23.3%
NZ_CP040938.1:
Lanthipeptides: B5772_RS02455_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
+ +V AS A CPT C++KC
5
IPCAVMASTAICPTLVCSNKC
25
23.3%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17435_lanthipeptide
26
SVAASAAFCPTTKCTSKC
43
+V SAA CPT+ CT+ C
17
TVTLSAASCPTSACTNLC
34
23.3%
NZ_CP085411.1:
Lanthipeptides: LIT28_RS29915_lanthipeptide
28
AASAAFCPTTKCTSKC
43
A+ + CPTTKCTS+C
20
GATISVCPTTKCTSRC
35
23.3%
NZ_JAHXMW010000012.1:
Lanthipeptides: KZX51_RS23840_lanthipeptide
12
EEWHGGTGPLCVAASVAASAAFCPTTKCTSKC
43
W P + ++ SA CP+T C+S+C
7
SSWPCAIVPPVLIWTITDSANSCPSTACSSRC
38
23.3%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12965_lanthipeptide
25
ASVAASAAFCPTTKCTSKC
43
A+ AA FCPT CT++C
14
AATAALPGFCPTGACTTRC
32
23.3%
NZ_JFCR01000001.1:
Lanthipeptides: JQ44_RS10210_lanthipeptide
30
SAAFCPTTKCTSKC
43
S A CPTTKC+S C
13
SVALCPTTKCSSAC
26
23.3%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21840_lanthipeptide
20
PLCVAASVAASAAFCPTTKCTSKC
43
P + +++ S A+CPT+KCT +C
6
PCGIGSTITISIAYCPTSKCTERC
29
23.3%
NZ_QNUC01000031.1:
Lanthipeptides: DN396_RS23045_lanthipeptide
28
AASAAFCPTTKCTSKC
43
A+ + CPTTKCTS+C
20
GATISICPTTKCTSRC
35
20.9%
NC_023073.1:
Lanthipeptides: U722_RS19995_lanthipeptide
30
SAAFCPTTKCTS
41
S A CPTTKC S
18
SLAGCPTTKCAS
29
20.9%
NZ_CKMQ01000043.1:
Lanthipeptides: AE832_RS09950_lanthipeptide
23
VAASVAASAAFCPTTKCTSKC
43
V +V +A CPT+ CT C
15
VTFTVTLNAGACPTSGCTKSC
35
20.9%
NZ_CP040417.1:
Lanthipeptides: FE328_RS09035_lanthipeptide
27
VAASAAFCPTTKCTS
41
V S A CP+TKC S
7
VPISLAICPSTKCAS
21
20.9%
NZ_CP101913.1:
Lanthipeptides: NP440_RS09140_lanthipeptide
26
SVAASAAFCPTTKCTS
41
++ SAA CPTT+C S
11
TIPISAAICPTTQCAS
26
20.9%
NZ_JACSPU010000002.1:
Lanthipeptides: H9630_RS06770_lanthipeptide
13
EWHGGTGPLCVAASVAASAAF
33
+ + T PLC+AAS+ A+ F
2
DVNAETTPLCIAASIGATIIF
22
20.9%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15520_lanthipeptide
23
VAASVAASAAFCPTTKCTS
41
+ ++ S A CPTTKC S
10
LTVTIPISLAGCPTTKCAS
28
20.9%
NZ_KQ040792.1:
Lanthipeptides: WH45_RS23705_lanthipeptide
24
AASVAASAAFCPTTKCTS
41
A + S A CPTT+C S
10
ATIIPVSLAICPTTRCAS
27
20.9%
NZ_KV917378.1:
Lanthipeptides: BK581_RS20095_lanthipeptide
26
SVAASAAFCPTTKCTS
41
++ SAA CPTT+C S
12
TIPISAAACPTTQCAS
27
20.9%
NZ_MLKL01000042.1:
Lanthipeptides: BKK45_RS27405_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
VA S CPT CT C
15
VAVSVKLCPTGVCTKSC
31
20.9%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS31015_lanthipeptide
32
AFCPTTKCTSKC
43
AFCPT+KCT++C
1
AFCPTSKCTTRC
12
20.9%
NZ_PCGR01000003.1:
Lanthipeptides: CQS04_RS09625_lanthipeptide
30
SAAFCPTTKCTSKC
43
SA CPTT CT C
15
SANSCPTTACTRAC
28
18.6%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04090_lanthipeptide
27
VAASAAFCPTTKCTS
41
+ S A CPTT+C S
9
IPISLAACPTTRCAS
23
18.6%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00775_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
+ S A CPTT+C+ +C
7
IPISIALCPTTRCSRRC
23
18.6%
NZ_CP115450.1:
Lanthipeptides: O1G21_RS35405_lanthipeptide
34
CPTTKCTSKC
43
CPTT CTS+C
12
CPTTACTSRC
21
18.6%
NZ_GG657754.1:
Lanthipeptides: SSOG_RS27835_lanthipeptide
34
CPTTKCTSKC
43
CPT+ CTSKC
1
CPTSGCTSKC
10
18.6%
NZ_JANIOB010000033.1:
Lanthipeptides: NQ113_RS28015_lanthipeptide
32
AFCPTTKCTSKC
43
A CPT +CTS+C
21
ALCPTPRCTSRC
32
18.6%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00150_lanthipeptide
30
SAAFCPTTKCTSKC
43
+AA CP+T CT C
18
TAALCPSTACTGDC
31
16.3%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20280_lanthipeptide
27
VAASAAFCPTTKCTSKC
43
V + CP+ CTS+C
17
VNLTKELCPSIPCTSRC
33
16.3%
NZ_NVJC01000007.1:
Lanthipeptides: COM38_RS07270_lanthipeptide
28
AASAAFCPTTKC
39
A+ + CPTTKC
20
GATISVCPTTKC
31
14.0%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27165_lanthipeptide
33
FCPTTKCTSKC
43
CP+ CTS+C
23
LCPSIPCTSRC
33
MIBiG 3.1 matches for brtA2
60.5%
BGC0002110 (QKV49894.1):
Lanthipeptide: birimositide
18
TGPLCVAASVAASAAFCPTTKCTSKC
43
TGPLCVAASVAASAAFCPTTKCTSKC
1
TGPLCVAASVAASAAFCPTTKCTSKC
26
32.6%
BGC0001229 (SBI_06989):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
26
SVAASAAFCPTTKCTSKC
43
+V SAAFCPTTKCTS+C
20
AVGVSAAFCPTTKCTSRC
37
Legend:
Dha: Didehydroalanine
Dhb: Didehydrobutyrine